Citius Oncology Inc. (CTOR)

0.65

-0.01 (-0.76%)

At close: Mar 28, 2025, 3:58 PM

Citius Oncology Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22
Net Income	-21.15M	-12.7M	-5.43M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	7.5M	1.97M	n/a
Other Working Capital	10.78M	8.61M	4.74M
Other Non-Cash Items	n/a	n/a	n/a
Deferred Income Tax	576K	576K	576K
Change in Working Capital	13.2M	10.16M	4.86M
Operating Cash Flow	126.35K	n/a	n/a
Capital Expenditures	-5M	n/a	n/a
Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	-5M	n/a	n/a
Debt Repayment	3.8M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	1.07M	n/a	n/a
Financial Cash Flow	4.87M	n/a	n/a
Net Cash Flow	112.00	n/a	n/a
Free Cash Flow	-4.87M	n/a	n/a